1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 ANG-3070 1.2.3 CIM-2 1.2.4 CR-8 1.2.5 Others 1.3 Market by Application 1.3.1 Global Polycystic Kidney Disease Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Clinic 1.3.3 Research Center 1.3.4 Hospital 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Polycystic Kidney Disease Treatment Market Size (2017-2028) 2.2 Polycystic Kidney Disease Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Polycystic Kidney Disease Treatment Market Size by Region (2017-2022) 2.4 Global Polycystic Kidney Disease Treatment Market Size Forecast by Region (2023-2028) 2.5 Global Top Polycystic Kidney Disease Treatment Countries Ranking by Market Size 3 Polycystic Kidney Disease Treatment Competitive by Company 3.1 Global Polycystic Kidney Disease Treatment Revenue by Players 3.1.1 Global Polycystic Kidney Disease Treatment Revenue by Players (2017-2022) 3.1.2 Global Polycystic Kidney Disease Treatment Market Share by Players (2017-2022) 3.2 Global Polycystic Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Polycystic Kidney Disease Treatment Revenue 3.4 Global Polycystic Kidney Disease Treatment Market Concentration Ratio 3.4.1 Global Polycystic Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Polycystic Kidney Disease Treatment Revenue in 2021 3.5 Global Polycystic Kidney Disease Treatment Key Players Head office and Area Served 3.6 Key Players Polycystic Kidney Disease Treatment Product Solution and Service 3.7 Date of Enter into Polycystic Kidney Disease Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Polycystic Kidney Disease Treatment Breakdown Data by Type 4.1 Global Polycystic Kidney Disease Treatment Historic Revenue by Type (2017-2022) 4.2 Global Polycystic Kidney Disease Treatment Forecasted Revenue by Type (2023-2028) 5 Global Polycystic Kidney Disease Treatment Breakdown Data by Application 5.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Application (2017-2022) 5.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) 6.2 North America Polycystic Kidney Disease Treatment Revenue by Type (2017-2028) 6.3 North America Polycystic Kidney Disease Treatment Revenue by Application (2017-2028) 6.4 North America Polycystic Kidney Disease Treatment Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) 7.2 Europe Polycystic Kidney Disease Treatment Revenue by Type (2017-2028) 7.3 Europe Polycystic Kidney Disease Treatment Revenue by Application (2017-2028) 7.4 Europe Polycystic Kidney Disease Treatment Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) 8.2 Asia Pacific Polycystic Kidney Disease Treatment Revenue by Type (2017-2028) 8.3 Asia Pacific Polycystic Kidney Disease Treatment Revenue by Application (2017-2028) 8.4 Asia Pacific Polycystic Kidney Disease Treatment Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) 9.2 Latin America Polycystic Kidney Disease Treatment Revenue by Type (2017-2028) 9.3 Latin America Polycystic Kidney Disease Treatment Revenue by Application (2017-2028) 9.4 Latin America Polycystic Kidney Disease Treatment Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) 10.2 Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Type (2017-2028) 10.3 Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Application (2017-2028) 10.4 Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 U.A.E 11 Company Profiles 11.1 Angion Biomedica Corp 11.1.1 Angion Biomedica Corp Company Details 11.1.2 Angion Biomedica Corp Business Overview 11.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Products and Services 11.1.4 Angion Biomedica Corp Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.1.5 Angion Biomedica Corp Polycystic Kidney Disease Treatment SWOT Analysis 11.1.6 Angion Biomedica Corp Recent Developments 11.2 Aptevo Therapeutics Inc 11.2.1 Aptevo Therapeutics Inc Company Details 11.2.2 Aptevo Therapeutics Inc Business Overview 11.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Products and Services 11.2.4 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.2.5 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment SWOT Analysis 11.2.6 Aptevo Therapeutics Inc Recent Developments 11.3 Celgene Corp 11.3.1 Celgene Corp Company Details 11.3.2 Celgene Corp Business Overview 11.3.3 Celgene Corp Polycystic Kidney Disease Treatment Products and Services 11.3.4 Celgene Corp Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.3.5 Celgene Corp Polycystic Kidney Disease Treatment SWOT Analysis 11.3.6 Celgene Corp Recent Developments 11.4 Conatus Pharmaceuticals Inc 11.4.1 Conatus Pharmaceuticals Inc Company Details 11.4.2 Conatus Pharmaceuticals Inc Business Overview 11.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Products and Services 11.4.4 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.4.5 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment SWOT Analysis 11.4.6 Conatus Pharmaceuticals Inc Recent Developments 11.5 DiscoveryBiomed Inc 11.5.1 DiscoveryBiomed Inc Company Details 11.5.2 DiscoveryBiomed Inc Business Overview 11.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Products and Services 11.5.4 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.5.5 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment SWOT Analysis 11.5.6 DiscoveryBiomed Inc Recent Developments 11.6 Endocyte Inc 11.6.1 Endocyte Inc Company Details 11.6.2 Endocyte Inc Business Overview 11.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Products and Services 11.6.4 Endocyte Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.6.5 Endocyte Inc Polycystic Kidney Disease Treatment SWOT Analysis 11.6.6 Endocyte Inc Recent Developments 11.7 IC-MedTech Inc 11.7.1 IC-MedTech Inc Company Details 11.7.2 IC-MedTech Inc Business Overview 11.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Products and Services 11.7.4 IC-MedTech Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.7.5 IC-MedTech Inc Polycystic Kidney Disease Treatment SWOT Analysis 11.7.6 IC-MedTech Inc Recent Developments 11.8 Ipsen SA 11.8.1 Ipsen SA Company Details 11.8.2 Ipsen SA Business Overview 11.8.3 Ipsen SA Polycystic Kidney Disease Treatment Products and Services 11.8.4 Ipsen SA Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.8.5 Ipsen SA Polycystic Kidney Disease Treatment SWOT Analysis 11.8.6 Ipsen SA Recent Developments 11.9 Kadmon Corp LLC 11.9.1 Kadmon Corp LLC Company Details 11.9.2 Kadmon Corp LLC Business Overview 11.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Products and Services 11.9.4 Kadmon Corp LLC Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.9.5 Kadmon Corp LLC Polycystic Kidney Disease Treatment SWOT Analysis 11.9.6 Kadmon Corp LLC Recent Developments 11.10 Madrigal Pharmaceuticals Inc. 11.10.1 Madrigal Pharmaceuticals Inc. Company Details 11.10.2 Madrigal Pharmaceuticals Inc. Business Overview 11.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Products and Services 11.10.4 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.10.5 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment SWOT Analysis 11.10.6 Madrigal Pharmaceuticals Inc. Recent Developments 11.11 ManRos Therapeutics 11.11.1 ManRos Therapeutics Company Details 11.11.2 ManRos Therapeutics Business Overview 11.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Products and Services 11.11.4 ManRos Therapeutics Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.11.5 ManRos Therapeutics Recent Developments 11.12 Metabolic Solutions Development Company LLC 11.12.1 Metabolic Solutions Development Company LLC Company Details 11.12.2 Metabolic Solutions Development Company LLC Business Overview 11.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Products and Services 11.12.4 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.12.5 Metabolic Solutions Development Company LLC Recent Developments 11.13 Mironid Ltd 11.13.1 Mironid Ltd Company Details 11.13.2 Mironid Ltd Business Overview 11.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Products and Services 11.13.4 Mironid Ltd Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) 11.13.5 Mironid Ltd Recent Developments 12 Polycystic Kidney Disease Treatment Market Dynamics 12.1 Polycystic Kidney Disease Treatment Market Trends 12.2 Polycystic Kidney Disease Treatment Market Drivers 12.3 Polycystic Kidney Disease Treatment Market Challenges 12.4 Polycystic Kidney Disease Treatment Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of ANG-3070 Table 3. Key Players of CIM-2 Table 4. Key Players of CR-8 Table 5. Key Players of Others Table 6. Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Polycystic Kidney Disease Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 8. Global Polycystic Kidney Disease Treatment Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Polycystic Kidney Disease Treatment Revenue Market Share by Region (2017-2022) Table 10. Global Polycystic Kidney Disease Treatment Revenue by Players (2017-2022) & (US$ Million) Table 11. Global Polycystic Kidney Disease Treatment Market Share by Players (2017-2022) Table 12. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Kidney Disease Treatment as of 2021) Table 13. Ranking of Global Top Polycystic Kidney Disease Treatment Companies by Revenue (US$ Million) in 2021 Table 14. Global 5 Largest Players Market Share by Polycystic Kidney Disease Treatment Revenue (CR5 and HHI) & (2017-2022) Table 15. Key Players Headquarters and Area Served Table 16. Key Players Polycystic Kidney Disease Treatment Product Solution and Service Table 17. Date of Key Manufacturers Enter into Polycystic Kidney Disease Treatment Market Table 18. Mergers & Acquisitions, Expansion Plans Table 19. Global Polycystic Kidney Disease Treatment Market Size by Type (2017-2022) & (US$ Million) Table 20. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2017-2022) Table 21. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 22. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2023-2028) Table 23. Global Polycystic Kidney Disease Treatment Market Size by Application (2017-2022) & (US$ Million) Table 24. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2017-2022) Table 25. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 26. Global Polycystic Kidney Disease Treatment Revenue Market Share by Application (2023-2028) Table 27. North America Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 28. North America Polycystic Kidney Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 29. North America Polycystic Kidney Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 30. North America Polycystic Kidney Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 31. North America Polycystic Kidney Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 32. North America Polycystic Kidney Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 33. North America Polycystic Kidney Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 34. Europe Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 35. Europe Polycystic Kidney Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 36. Europe Polycystic Kidney Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 37. Europe Polycystic Kidney Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 38. Europe Polycystic Kidney Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 39. Europe Polycystic Kidney Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 40. Europe Polycystic Kidney Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 41. Asia Pacific Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 42. Asia Pacific Polycystic Kidney Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 43. Asia Pacific Polycystic Kidney Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 44. Asia Pacific Polycystic Kidney Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 45. Asia Pacific Polycystic Kidney Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 46. Asia Pacific Polycystic Kidney Disease Treatment Revenue by Region (2017-2022) & (US$ Million) Table 47. Asia Pacific Polycystic Kidney Disease Treatment Revenue by Region (2023-2028) & (US$ Million) Table 48. Latin America Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 49. Latin America Polycystic Kidney Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 50. Latin America Polycystic Kidney Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 51. Latin America Polycystic Kidney Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 52. Latin America Polycystic Kidney Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 53. Latin America Polycystic Kidney Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 54. Latin America Polycystic Kidney Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Company (2020-2022) & (US$ Million) Table 56. Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Polycystic Kidney Disease Treatment Revenue by Country (2023-2028) & (US$ Million) Table 62. Angion Biomedica Corp Company Details Table 63. Angion Biomedica Corp Business Overview Table 64. Angion Biomedica Corp Polycystic Kidney Disease Treatment Product and Services Table 65. Angion Biomedica Corp Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 66. Angion Biomedica Corp Polycystic Kidney Disease Treatment SWOT Analysis Table 67. Angion Biomedica Corp Recent Developments Table 68. Aptevo Therapeutics Inc Company Details Table 69. Aptevo Therapeutics Inc Business Overview Table 70. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Product and Services Table 71. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 72. Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment SWOT Analysis Table 73. Aptevo Therapeutics Inc Recent Developments Table 74. Celgene Corp Company Details Table 75. Celgene Corp Business Overview Table 76. Celgene Corp Polycystic Kidney Disease Treatment Product and Services Table 77. Celgene Corp Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 78. Celgene Corp Polycystic Kidney Disease Treatment SWOT Analysis Table 79. Celgene Corp Recent Developments Table 80. Conatus Pharmaceuticals Inc Company Details Table 81. Conatus Pharmaceuticals Inc Business Overview Table 82. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Product and Services Table 83. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 84. Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment SWOT Analysis Table 85. Conatus Pharmaceuticals Inc Recent Developments Table 86. DiscoveryBiomed Inc Company Details Table 87. DiscoveryBiomed Inc Business Overview Table 88. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Product and Services Table 89. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 90. DiscoveryBiomed Inc Polycystic Kidney Disease Treatment SWOT Analysis Table 91. DiscoveryBiomed Inc Recent Developments Table 92. Endocyte Inc Company Details Table 93. Endocyte Inc Business Overview Table 94. Endocyte Inc Polycystic Kidney Disease Treatment Product and Services Table 95. Endocyte Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 96. Endocyte Inc Polycystic Kidney Disease Treatment SWOT Analysis Table 97. Endocyte Inc Recent Developments Table 98. IC-MedTech Inc Company Details Table 99. IC-MedTech Inc Business Overview Table 100. IC-MedTech Inc Polycystic Kidney Disease Treatment Product and Services Table 101. IC-MedTech Inc Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 102. IC-MedTech Inc Polycystic Kidney Disease Treatment SWOT Analysis Table 103. IC-MedTech Inc Recent Developments Table 104. Ipsen SA Company Details Table 105. Ipsen SA Business Overview Table 106. Ipsen SA Polycystic Kidney Disease Treatment Product and Services Table 107. Ipsen SA Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 108. Ipsen SA Polycystic Kidney Disease Treatment SWOT Analysis Table 109. Ipsen SA Recent Developments Table 110. Kadmon Corp LLC Company Details Table 111. Kadmon Corp LLC Business Overview Table 112. Kadmon Corp LLC Polycystic Kidney Disease Treatment Product and Services Table 113. Kadmon Corp LLC Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 114. Kadmon Corp LLC Polycystic Kidney Disease Treatment SWOT Analysis Table 115. Kadmon Corp LLC Recent Developments Table 116. Madrigal Pharmaceuticals Inc. Company Details Table 117. Madrigal Pharmaceuticals Inc. Business Overview Table 118. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Product and Services Table 119. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 120. Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment SWOT Analysis Table 121. Madrigal Pharmaceuticals Inc. Recent Developments Table 122. ManRos Therapeutics Company Details Table 123. ManRos Therapeutics Business Overview Table 124. ManRos Therapeutics Polycystic Kidney Disease Treatment Product and Services Table 125. ManRos Therapeutics Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 126. ManRos Therapeutics Recent Developments Table 127. Metabolic Solutions Development Company LLC Company Details Table 128. Metabolic Solutions Development Company LLC Business Overview Table 129. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Product and Services Table 130. Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 131. Metabolic Solutions Development Company LLC Recent Developments Table 132. Mironid Ltd Company Details Table 133. Mironid Ltd Business Overview Table 134. Mironid Ltd Polycystic Kidney Disease Treatment Product and Services Table 135. Mironid Ltd Polycystic Kidney Disease Treatment Revenue in Polycystic Kidney Disease Treatment Business (2017-2022) & (US$ Million) Table 136. Mironid Ltd Recent Developments Table 137. Polycystic Kidney Disease Treatment Market Trends Table 138. Polycystic Kidney Disease Treatment Market Drivers Table 139. Polycystic Kidney Disease Treatment Market Challenges Table 140. Polycystic Kidney Disease Treatment Market Restraints Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Polycystic Kidney Disease Treatment Sales Market Share by Type: 2021 VS 2028 Figure 2. ANG-3070 Features Figure 3. CIM-2 Features Figure 4. CR-8 Features Figure 5. Others Features Figure 6. Global Polycystic Kidney Disease Treatment Sales Market Share by Application: 2021 VS 2028 Figure 7. Clinic Case Studies Figure 8. Research Center Case Studies Figure 9. Hospital Case Studies Figure 10. Polycystic Kidney Disease Treatment Report Years Considered Figure 11. Global Polycystic Kidney Disease Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Polycystic Kidney Disease Treatment Market Size 2017-2028 (US$ Million) Figure 13. Global Polycystic Kidney Disease Treatment Market Size Market Share by Region: 2021 VS 2028 Figure 14. Global Polycystic Kidney Disease Treatment Revenue Market Share by Region in 2017 VS 2022 Figure 15. Global Top 10 Polycystic Kidney Disease Treatment Countries Ranking by Market Size (US$ Million) in 2021 Figure 16. Global Polycystic Kidney Disease Treatment Market Share by Players in 2021 Figure 17. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Kidney Disease Treatment as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Polycystic Kidney Disease Treatment Revenue in 2021 Figure 19. North America Polycystic Kidney Disease Treatment Revenue Market Share by Company in 2021 Figure 20. North America Polycystic Kidney Disease Treatment Revenue Market Share by Type (2017-2028) Figure 21. North America Polycystic Kidney Disease Treatment Revenue Market Share by Application (2017-2028) Figure 22. North America Polycystic Kidney Disease Treatment Revenue Share by Country (2017-2028) Figure 23. U.S. Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 24. Canada Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 25. Europe Polycystic Kidney Disease Treatment Revenue Market Share by Company in 2021 Figure 26. Europe Polycystic Kidney Disease Treatment Revenue Market Share by Type (2017-2028) Figure 27. Europe Polycystic Kidney Disease Treatment Revenue Market Share by Application (2017-2028) Figure 28. Europe Polycystic Kidney Disease Treatment Revenue Share by Country (2017-2028) Figure 29. Germany Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 30. France Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 31. U.K. Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 32. Italy Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 33. Russia Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 34. Asia Pacific Polycystic Kidney Disease Treatment Revenue Market Share by Company in 2021 Figure 35. Asia Pacific Polycystic Kidney Disease Treatment Revenue Market Share by Type (2017-2028) Figure 36. Asia Pacific Polycystic Kidney Disease Treatment Revenue Market Share by Application (2017-2028) Figure 37. Asia Pacific Polycystic Kidney Disease Treatment Revenue Share by Region (2017-2028) Figure 38. China Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 39. Japan Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 40. South Korea Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 41. India Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 42. Australia Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 43. Taiwan Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 44. Indonesia Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 45. Thailand Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 46. Malaysia Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 47. Philippines Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 48. Vietnam Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 49. Latin America Polycystic Kidney Disease Treatment Revenue Market Share by Company in 2021 Figure 50. Latin America Polycystic Kidney Disease Treatment Revenue Market Share by Type (2017-2028) Figure 51. Latin America Polycystic Kidney Disease Treatment Revenue Market Share by Application (2017-2028) Figure 52. Latin America Polycystic Kidney Disease Treatment Revenue Share by Country (2017-2028) Figure 53. Mexico Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 54. Brazil Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 55. Argentina Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 56. Middle East and Africa Polycystic Kidney Disease Treatment Revenue Market Share by Company in 2021 Figure 57. Middle East and Africa Polycystic Kidney Disease Treatment Revenue Market Share by Type (2017-2028) Figure 58. Middle East and Africa Polycystic Kidney Disease Treatment Revenue Market Share by Application (2017-2028) Figure 59. Middle East and Africa Polycystic Kidney Disease Treatment Revenue Share by Country (2017-2028) Figure 60. Turkey Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 61. Saudi Arabia Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 62. U.A.E Polycystic Kidney Disease Treatment Revenue (2017-2028) & (US$ Million) Figure 63. Angion Biomedica Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 64. Aptevo Therapeutics Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 65. Celgene Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 66. Conatus Pharmaceuticals Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 67. DiscoveryBiomed Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 68. Endocyte Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 69. IC-MedTech Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 70. Ipsen SA Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 71. Kadmon Corp LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 72. Madrigal Pharmaceuticals Inc. Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 73. ManRos Therapeutics Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 74. Metabolic Solutions Development Company LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 75. Mironid Ltd Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2017-2022) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Angion Biomedica Corp Aptevo Therapeutics Inc Celgene Corp Conatus Pharmaceuticals Inc DiscoveryBiomed Inc Endocyte Inc IC-MedTech Inc Ipsen SA Kadmon Corp LLC Madrigal Pharmaceuticals Inc. ManRos Therapeutics Metabolic Solutions Development Company LLC Mironid Ltd